| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 8, Issue 2 231-242, Copyright © 1997 by American Association of Cancer Research
ARTICLES |
SC Kiley and PJ Parker
Protein Phosphorylation Laboratory, Imperial Cancer Research Fund, London, United Kingdom.
Phorbol ester-induced beta 2-integrin transport to the cell surface is defective in cloned 12-O-tetradecanoylphorbol-13-acetate (TPA)-resistant U937 cell variants. Failure of the integrin-containing vesicles to reach the plasma membrane effectively blocks development of all integrin-mediated responses and the formation of a functional oxidase complex. Several lines of evidence suggested that the underlying cause of this defect may be the loss of regulatory elements in the cytoskeleton, which mediate microtubule stability and organization. Diminished protein kinase C (PKC) beta 2 association with microtubules correlated with the loss of heat-soluble microtubule-associated PKC-binding proteins and the loss of TPA-inducible reorganization of the microtubule cytoskeleton in the resistant U937 variants. Treatment with the microtubule-disrupting drug, nocodazole, was sufficient to induce the modest increase in cd11b surface expression associated with the release of this preformed integrin. Furthermore, brief nocodazole treatment followed by TPA treatment completely restored susceptibility to phorbol ester-induced differentiation in the resistant cell lines. The combination of nocodazole and TPA treatment also restored NADPH oxidase activity in the TPA-resistant clones. Results from these studies suggest that TPA-induced microtubule reorganization is a prerequisite for integrin vesicle translocation in U937 cells and that vesicle translocation to the plasma membrane may be a prerequisite for the transcriptional activation of cd11b and cd11c integrin genes in the early stages of monocyte differentiation.
This article has been cited by other articles:
![]() |
S. Cathelin, C. Rebe, L. Haddaoui, N. Simioni, F. Verdier, M. Fontenay, S. Launay, P. Mayeux, and E. Solary Identification of Proteins Cleaved Downstream of Caspase Activation in Monocytes Undergoing Macrophage Differentiation J. Biol. Chem., June 30, 2006; 281(26): 17779 - 17788. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chen, A. Purohit, E. Halilovic, S. J. Doxsey, and A. C. Newton Centrosomal Anchoring of Protein Kinase C {beta}II by Pericentrin Controls Microtubule Organization, Spindle Function, and Cytokinesis J. Biol. Chem., February 6, 2004; 279(6): 4829 - 4839. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakhost, N. Kabir, P. Forscher, and W. S. Sossin Protein Kinase C Isoforms Are Translocated to Microtubules in Neurons J. Biol. Chem., October 18, 2002; 277(43): 40633 - 40639. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, L. Zhang, J. Z. Fields, A. Farhadi, D. A. Talmage, and A. Keshavarzian PKC-zeta prevents oxidant-induced iNOS upregulation and protects the microtubules and gut barrier integrity Am J Physiol Gastrointest Liver Physiol, October 1, 2002; 283(4): G909 - G922. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, J. Z. Fields, D. A. Talmage, Y. Zhang, and A. Keshavarzian PKC-{beta}1 mediates EGF protection of microtubules and barrier of intestinal monolayers against oxidants Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G833 - G847. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Long, D. Kelleher, S. Lynch, and Y. Volkov Cutting Edge: Protein Kinase C{{beta}} Expression Is Critical for Export of IL-2 from T Cells J. Immunol., July 15, 2001; 167(2): 636 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, J. Z. Fields, Y. Zhang, and A. Keshavarzian Key role of PKC and Ca2+ in EGF protection of microtubules and intestinal barrier against oxidants Am J Physiol Gastrointest Liver Physiol, May 1, 2001; 280(5): G828 - G843. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jagannath, M. R. Emanuele, and R. L. Hunter Activities of Poloxamer CRL-1072 against Mycobacterium avium in Macrophage Culture and in Mice Antimicrob. Agents Chemother., December 1, 1999; 43(12): 2898 - 2903. [Abstract] [Full Text] |
||||
![]() |
J. P. HATTON, F. GAUBERT, M. L. LEWIS, Y. DARSEL, P. OHLMANN, J.-P. CAZENAVE, and D. SCHMITT The kinetics of translocation and cellular quantity of protein kinase C in human leukocytes are modified during spaceflight FASEB J, May 1, 1999; 13(9001): 23 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. H. Whelan, S. C. Kiley, and P. J. Parker Tetradecanoyl Phorbol Acetate-induced Microtubule Reorganization Is Required for Sustained Mitogen-activated Protein Kinase Activation and Morphological Differentiation of U937 Cells Cell Growth Differ., April 1, 1999; 10(4): 271 - 277. [Abstract] [Full Text] |
||||
![]() |
E. J. PETTIT Cytosolic Free Calcium and the Cytoskeleton in the Control of Leukocyte Chemotaxis Physiol Rev, October 1, 1998; 78(4): 949 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Banan, J. Z. Fields, D. A. Talmage, L. Zhang, and A. Keshavarzian PKC-zeta is required in EGF protection of microtubules and intestinal barrier integrity against oxidant injury Am J Physiol Gastrointest Liver Physiol, May 1, 2002; 282(5): G794 - G808. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |